Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01007357 |
Recruitment Status
:
Terminated
(Principal Investigator left institution; did not complete the study)
First Posted
: November 4, 2009
Last Update Posted
: November 13, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diffuse and Focal Abnormalities of the Liver and Pancreas | Device: Body MR imaging | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation |
Study Start Date : | December 2009 |
Actual Primary Completion Date : | June 2015 |
Actual Study Completion Date : | June 2015 |

Arm | Intervention/treatment |
---|---|
No Intervention: Body MRI healthy volunteers
Body MRI to optimize sequences in healthy individuals and in disorder subjects
|
Device: Body MR imaging
Body MR imaging will be performed to optimize sequences
Other Name: Body MR imaging performed to optimize sequences
|
- to optimize body MR imaging sequences [ Time Frame: 2 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subjects between ages of 19 and 65
- Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
- Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)
Exclusion Criteria:
- Inability to provide informed consent
- A medical or contraindications that will prevent subjects from having a MRI
- Subjects with severe renal dysfunction or patients on dialysis

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01007357
United States, Nebraska | |
University of Nebraska Medical Center | |
Omaha, Nebraska, United States, 68198-1045 | |
University of Nebraska Medical Center | |
Omaha, Nebraska, United States, 68198 |
Principal Investigator: | Shahid Hussain, MD | University of Nebraska |
Responsible Party: | University of Nebraska |
ClinicalTrials.gov Identifier: | NCT01007357 History of Changes |
Other Study ID Numbers: |
290-09 |
First Posted: | November 4, 2009 Key Record Dates |
Last Update Posted: | November 13, 2015 |
Last Verified: | November 2015 |